Form 4: BioXcel CFO Richard Steinhart Exercises RSU Grant
Statement of Changes in Beneficial Ownership
BioXcel Therapeutics CFO Richard Steinhart acquired 9,000 shares of common stock following the vesting of restricted stock units.
Summary
- CFO Richard Steinhart acquired 9,000 shares of BioXcel Therapeutics common stock on May 1, 2026.
- The acquisition resulted from the vesting of 9,000 Restricted Stock Units (RSUs) granted on August 1, 2025.
- Following this transaction, the reporting person holds a total of 15,645 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative filing regarding standard executive equity compensation.
Positives
- The transaction reflects the fulfillment of equity-based compensation incentives for the Chief Financial Officer.
Negatives
- None identified.
Risks
- Continued employment requirements for equity vesting.
Future Outlook
No forward-looking guidance provided in this filing.
Industry Context
StockSavvy.ai notes that this is a routine disclosure of executive compensation vesting, common in the biotechnology sector to align management interests with long-term shareholder value.
Comparison to Industry Standards
- The vesting schedule and equity compensation structure are consistent with standard executive compensation practices for mid-cap biotechnology firms.
Stakeholder Impact
- Minimal impact on shareholders as this represents standard compensation vesting.
Next Steps
- None mentioned.
Key Dates
| Date | Description |
|---|---|
| 08/01/2025 | Grant date of the Restricted Stock Units. |
| 05/01/2026 | Transaction date of RSU vesting and share acquisition. |
| 05/07/2026 | Date of filing. |
Keywords
BioXcel Therapeutics, BTAI, Insider Trading, Form 4, CFO, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.